Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.448 EUR | +0.67% | +4.17% | +31.65% |
01:23pm | China BlueChemical Unit Invests 150 Million Yuan in Structured Deposits | MT |
06-06 | China Central Bank Infuses 2 Billion Yuan in Liquidity on Thursday | MT |
Strengths
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Its low valuation, with P/E ratio at 5.07 and 4.93 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company's share price in relation to its net book value makes it look relatively cheap.
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
Ratings chart - Surperformance
Sector: Banks
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+31.65% | 172B | - | ||
+17.55% | 574B | C+ | ||
+18.15% | 311B | C+ | ||
+15.71% | 254B | C+ | ||
+18.57% | 203B | C | ||
+21.72% | 184B | B- | ||
+9.47% | 163B | C+ | ||
+9.22% | 150B | B- | ||
-8.66% | 143B | B- | ||
+12.30% | 138B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 3988 Stock
- W8V Stock
- Ratings Bank of China Limited